Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-21

Clinical Trial Update: Post-Marketing Surveillance Study of Nalmefene Hydrochloride Hydrate in Patients with Alcohol Dependence

View source ↗

Summary

This entry reports the completion of a post-marketing surveillance study evaluating nalmefene hydrochloride hydrate in patients with alcohol dependence.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nalmefene hydrochloride hydrate (nalmefene)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Alcohol Dependence | Status: COMPLETED